INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 46 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,443,000 | -0.7% | 4,845,000 | 0.0% | 0.13% | -8.6% |
| Q4 2020 | $5,483,000 | +3.6% | 4,845,000 | 0.0% | 0.14% | -10.8% |
| Q3 2020 | $5,294,000 | +8.0% | 4,845,000 | -3.5% | 0.16% | +0.6% |
| Q2 2020 | $4,904,000 | +27.4% | 5,020,000 | +10.3% | 0.16% | +14.7% |
| Q1 2020 | $3,848,000 | +12.2% | 4,550,000 | +28.2% | 0.14% | +40.2% |
| Q4 2019 | $3,431,000 | +15.1% | 3,550,000 | 0.0% | 0.10% | +6.6% |
| Q3 2019 | $2,982,000 | -13.7% | 3,550,000 | 0.0% | 0.09% | -15.0% |
| Q2 2019 | $3,454,000 | -3.5% | 3,550,000 | 0.0% | 0.11% | -7.0% |
| Q1 2019 | $3,579,000 | +40.9% | 3,550,000 | 0.0% | 0.12% | +23.7% |
| Q4 2018 | $2,541,000 | -28.9% | 3,550,000 | -15.5% | 0.09% | -6.1% |
| Q3 2018 | $3,575,000 | -7.5% | 4,200,000 | 0.0% | 0.10% | -11.6% |
| Q2 2018 | $3,866,000 | +36.3% | 4,200,000 | +31.2% | 0.11% | +16.7% |
| Q1 2018 | $2,836,000 | – | 3,200,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |